Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Noah Auerhahn, Ryan Lim · 2 co-founders
Profile coverage4 of 8 · missing Funding, Signals, Customers, Stack / tools · last run 8/10/2026
About
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.